 | • レポートコード：D0-MOR-AP0663 • 出版社/出版日：Mordor Intelligence / 2020年4月20日 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：健康管理 |
| Single User | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,110,000 (USD7,500) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ヒト胎盤由来タンパク質の世界市場について調査・分析した資料で、ヒト胎盤由来タンパク質の市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。 |
The Human Placental Protein Market is expected to register a CAGR of around 5% during the forecast period. Rising use of placental protein in cosmetics and medication to treat menopause is among the key factor triggering the growth of the human placental protein market. For instance, several products are in the human placental market which is promoting the revenue growth, Melsmon pharmaceuticals are producing pharmaceutical-grade placenta which is used for treating menopause. In addition, Japan Bio Products has Laennec which treats chronic hepatitis and another company Alber David has Inj.Placentrex. (wound healer).
The increase in R&D investments in healthcare coupled with the introduction of human placental protein in pseudo-medicines will create lucrative opportunities in the human placental protein market.
However, prolonged use of human placental proteins can cause skin dryness which hampers the market.
Key Market Trends
Skin Care Products in Human Placental Protein Segment is Expected to Hold Significant Market Share
Skin Care Products are expected to dominate the global human placental protein market in the forecast period. This can be attributed to the rising prevalence of cosmetics products among the targeted population and the increasing number of menopause population. As the placenta connects developing fetus to the uterine wall to all nutrients uptake, thermoregulation, fighting against internal infection and produce hormones to support pregnancy, which makes placenta protein highly nutritious and thus it further hydrolyzed and use it for many skincare products and hair care treatments.
In addition, with the increasing aging population worldwide, the human placental protein extract has been extensively used for anti-aging therapy and is promoting the growth of the overall market.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period
North America is expected to hold a significant market share in the global Human Placental Protein market attributing to an increasingly aging population with a higher rate of menopause population in this region. According to the National Institute of Health, approximately 1.3 million women become menopausal each year and 5% experience early menopause in the United States. This is leading to the adoption of placental extract for treating menopausal, thus promote the growth of the human placental protein market. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.
Competitive Landscape
The market studied is moderately competitive and most of the companies operating in the market are the local players from various countries. Some of the companies which are currently getting the attention in the market are JAPAN BIO PRODUCTS Co., Ltd., VWR International, Takara Bio Inc, Abcam plc, Kamiya Biomedical Co, Scripps Laboratories, Lee BioSolutions and elabscience.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing use of Cosmetics Products
4.2.2 Increasing Ageing Population
4.3 Market Restraints
4.3.1 Adverse Effects
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Hydrolyzed Human Placental Protein
5.1.2 Human Placental Enzymes
5.1.3 Others
5.2 By Application
5.2.1 Tumor markers
5.2.2 Life sciences
5.2.3 Others
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 JAPAN BIO PRODUCTS Co., Ltd.
6.1.2 VWR International
6.1.3 Takara Bio Inc
6.1.4 Abcam plc
6.1.5 Kamiya Biomedical Co.
6.1.6 Scripps Laboratories
6.1.7 Lee BioSolutions
6.1.8 elabscience
7 MARKET OPPORTUNITIES AND FUTURE TRENDS